K Number
K013290
Device Name
MODIFIED 650 MAMMOGRAPHY SYSTEM
Date Cleared
2001-10-24

(22 days)

Product Code
Regulation Number
892.1710
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Modified 650 Mammography System is intended to produce radiographic images of the breast. Its specific intended use is for screening and diagnostic mammography. Screening mammography involves the production of images for initial examination for breast cancer diagnosis. Diagnosis mammography involves the production of magnified breast images, crease spot compression views, and the thorough examination of breast determined suspicious through screening mammography by a physician in preparation for biopsy.
Device Description
Not Found
More Information

Not Found

Not Found

No
The provided 510(k) summary does not contain any mention of AI, ML, deep learning, or any related terms, nor does it describe features or performance metrics typically associated with AI/ML-powered devices.

No
The device is described as an imaging system used for screening and diagnostic mammography, which are diagnostic procedures, not therapeutic ones.

Yes
The text explicitly states that the device's specific intended use is for "screening and diagnostic mammography." It further clarifies that "Diagnosis mammography involves the thorough examination of breast determined suspicious through screening mammography by a physician in preparation for biopsy," which is a diagnostic activity.

No

The device is described as a "Mammography System," which inherently implies hardware components for image acquisition (the mammography machine itself). The description focuses on the function of producing radiographic images, which is a hardware-dependent process.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD devices are used to examine specimens taken from the human body. The intended use of the Modified 650 Mammography System is to produce radiographic images of the breast directly from the patient. It does not involve analyzing samples like blood, urine, or tissue in a laboratory setting.
  • The description focuses on imaging the breast. The intended use and anatomical site clearly indicate that this is an imaging device used on a living patient.

Therefore, this device falls under the category of a medical imaging device, not an IVD.

N/A

Intended Use / Indications for Use

The Modified 650 Mammography System is intended to produce radiographic images of the breast. Its specific intended use is for screening and diagnostic mammography. Screening mammography involves the production of images for initial examination for breast cancer diagnosis. Diagnostic mammography involves the production of magnified breast images, special views, spot compression views, and the thorough examination of breast determined suspicious through screening mammography by a physician in preparation for biopsy.

Product codes

90 IZH

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

radiographic images

Anatomical Site

breast

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1710 Mammographic x-ray system.

(a)
Identification. A mammographic x-ray system is a device intended to be used to produce radiographs of the breast. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

Section 1.0

Safety and Effectiveness 510(k) Summary 1.3

  • The Modified 650 Mammography System has been designed for classification to 1. Underwriters Laboratories, Inc. (UL) to Standard 187.
    1. The Modified 650 Mammography System has been designed for classification by Underwriters Laboratories, Inc. to Canadian Standards Association, CSA Standard C22.2 No. 114.
    1. The Modified 650 Mammography System has been designed for certification to International Electrotechnical Commission Standard IEC-601-1
  • The Modified 650 Mammography System is tested and conforms to the Federal ধ Performance Standards for Ionizing Radiation Emitting Products, defined in 21 CFR 1000.
    1. The American College of Radiology (ACR) in Reston, Virginia, conducts a nationwide program that accredits providers of mammography services. To qualify for ACR accreditation, the mammography device at a provider site must meet ACR standards for image quality and operation within radiation dose limits. The Modified 650 Mammography System has been designed to meet the requirements for ACR accreditation.
    1. A comprehensive Operator's Manual provided with each system is user friendly and comprehensive, thus ensuring safe and effective operation of the Modified 650 Mammography System.

This information is provided pursuant to the requirements of the Safe Medical Devices Act of 1990 (SMDA).

1

Image /page/1/Picture/1 description: The image shows a logo for the Department of Health & Human Services. The logo features a stylized eagle with three lines representing its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES" are arranged in a circular fashion around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

OCT 2 4 2001

Ms. Roaida Rizkallah Regulatory Specialist LORAD Hologic Company 36 Apple Ridge Road DANBURY CT 06810

Re: K013290

Trade/Device Name: Affinity System (Modified 650 Mammography System) Regulation Number: 21 CFR 892.1710 Regulation Name: Mammographic x-ray System Regulatory Class: II Product Code: 90 IZH Dated: October 1, 2001 Received: October 2, 2001

Dear Ms. Rizkallah:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4654
Other(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely vours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

510(k) Number (if known): K013290

Device Name: Modified 650 Mammography System

Intended Use:

The Modified 650 Mammography System is intended to produce radiographic images of The Modified 630 Miammography Dyston screening and diagnostic manmography. the breast. Its specific intended use is for seroning for initial examination for Screening mammography involves the production of inlinges the production of magnified breast cancer diagnosis. Diagnosus manimography Libreast determined suspicious images for more unorough cxammation of crease spot compression views, and the unrough sereeming maniling - physician in preparation for biopsy.

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use ملك 21 CFR 801.109

OR

Over-the-Counter Use ___

Vassay C. boordon
(Division Sign-on)

Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K01329